Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) shares saw strong trading volume on Wednesday . 2,015,233 shares traded hands during trading, an increase of 76% from the previous session’s volume of 1,148,126 shares.The stock last traded at $22.39 and had previously closed at $21.60. Wall Street Analyst Weigh In A number of equities research […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Jennifer E. Cook sold 1,458 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $21.73, for a total transaction of $31,682.34. Following the transaction, the director now owns 20,038 shares in the company, valued at […]
Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]
Crestline Management LP lowered its position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) by 5.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 5,660,732 shares of the company’s stock after selling 300,000 shares during the period. Denali Therapeutics makes up 10.3% of Crestline Management LP’s holdings, making the stock its biggest position. […]
Capstone Investment Advisors LLC Decreases Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.